Inogen, Inc. (INGN) vs Neuronetics, Inc. (STIM)
A side-by-side comparison of Inogen, Inc. and Neuronetics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
INGN
Inogen, Inc.
$5.82HealthcareDelayed quote: Oct 6, 2026, 1:49 PM EDT
STIM
Neuronetics, Inc.
$2.24HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
Total return — INGN vs STIM
growth of $100 · dividends reinvested · last 8yINGN -96.8% (-35.0%/yr)STIM -92.1% (-27.2%/yr)STIM compounded faster over this window
INGN STIM
INGN vs STIM: by the numbers
- •INGN is the larger company ($158M vs $156M market cap).
- •Both run net losses; INGN's is the smaller (-6.94% vs -19.62% net margin).
- •STIM grew revenue faster over the past five years (23.26% vs 1.02% CAGR).
Metrics side by side
Valuation
| Metric | INGN | STIM |
|---|---|---|
| P/S ratio | 0.44 | 1.00 |
| P/B ratio | 0.90 | 8.71 |
Profitability
| Metric | INGN | STIM |
|---|---|---|
| Gross margin | 48.89% | 49.12% |
| Operating margin | -8.45% | -14.74% |
| Net margin | -6.94% | -19.62% |
| ROE | -14.07% | -170.49% |
| ROIC | -13.94% | -22.15% |
Growth (annualized)
| Metric | INGN | STIM |
|---|---|---|
| Revenue CAGR (5Y) | 1.02% | 23.26% |
| Total return CAGR (5Y) | -32.83% | -19.46% |
Frequently asked
- Which has grown faster, INGN or STIM?
- Over the past five years, STIM grew revenue faster — INGN at a 1.02% CAGR versus STIM at 23.26%.
- How have INGN and STIM total returns compared?
- Over the past 5 years, INGN delivered -32.83% and STIM delivered -19.46% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Inogen ROENeuronetics ROEInogen operating marginNeuronetics operating marginInogen revenue growthNeuronetics revenue growthInogen free cash flowNeuronetics free cash flow
Inogen & Neuronetics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.